Sawyer & Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.69M | Sell |
15,704
-109
| -0.7% | -$37.3K | 1.91% | 12 |
|
|
2026
Q1 | $5.56M | Sell |
15,813
-306
| -2% | -$109K | 2.14% | 11 |
|
|
2025
Q4 | $5.28M | Sell |
16,119
-35
| -0.2% | -$11.1K | 1.87% | 11 |
|
|
2025
Q3 | $4.51M | Buy |
16,154
+450
| +3% | +$131K | 1.7% | 18 |
|
|
2025
Q2 | $5.69M | Sell |
15,704
-49
| -0.3% | -$13.9K | 1.91% | 12 |
|
|
2025
Q1 | $4.91M | Sell |
15,753
-243
| -2% | -$71.8K | 1.98% | 14 |
|
|
2024
Q4 | $4.17M | Buy |
15,996
+57
| +0.4% | +$16.9K | 1.54% | 23 |
|
|
2024
Q3 | $5.14M | Buy |
15,939
+77
| +0.5% | +$25.2K | 1.9% | 16 |
|
|
2024
Q2 | $4.96M | Buy |
15,862
+9
| +0.1% | +$2.64K | 1.97% | 11 |
|
|
2024
Q1 | $4.51M | Sell |
15,853
-29,752
| -65% | -$8.71M | 1.8% | 17 |
|
|
2023
Q4 | $4.5M | Buy |
45,605
+29,570
| +184% | +$8.06M | 1.98% | 15 |
|
|
2023
Q3 | $4.31M | Buy |
16,035
+174
| +1% | +$43.4K | 2.01% | 14 |
|
|
2023
Q2 | $3.52M | Buy |
15,861
+142
| +0.9% | +$32.9K | 1.61% | 18 |
|
|
2023
Q1 | $3.94M | Buy |
15,719
+331
| +2% | +$81.3K | 2.12% | 14 |
|
|
2022
Q4 | $4.04M | Sell |
15,388
-187
| -1% | -$50.1K | 1.99% | 15 |
|
|
2022
Q3 | $3.51M | Buy |
15,575
+70
| +0.5% | +$17K | 1.91% | 16 |
|
|
2022
Q2 | $3.77M | Sell |
15,505
-700
| -4% | -$172K | 1.91% | 15 |
|
|
2022
Q1 | $3.92M | Buy |
16,205
+220
| +1% | +$50.5K | 1.76% | 15 |
|
|
2021
Q4 | $3.6M | Buy |
15,985
+132
| +0.8% | +$27.9K | 1.55% | 19 |
|
|
2021
Q3 | $3.37M | Buy |
15,853
+220
| +1% | +$50.6K | 1.59% | 18 |
|
|
2021
Q2 | $3.81M | Buy |
15,633
+345
| +2% | +$84.9K | 1.78% | 18 |
|
|
2021
Q1 | $3.8M | Buy |
15,288
+295
| +2% | +$70.4K | 1.89% | 18 |
|
|
2020
Q4 | $3.45M | Sell |
14,993
-155
| -1% | -$35.7K | 1.76% | 19 |
|
|
2020
Q3 | $3.85M | Buy |
15,148
+545
| +4% | +$135K | 2.29% | 13 |
|
|
2020
Q2 | $3.44M | Buy |
14,603
+2,635
| +22% | +$601K | 2.13% | 14 |
|
|
2020
Q1 | $2.43M | Buy |
11,968
+795
| +7% | +$174K | 1.94% | 12 |
|
|
2019
Q4 | $2.69M | Buy |
11,173
+771
| +7% | +$170K | 1.73% | 14 |
|
|
2019
Q3 | $2.01M | Sell |
10,402
-260
| -2% | -$49.9K | 1.43% | 20 |
|
|
2019
Q2 | $1.97M | Sell |
10,662
-360
| -3% | -$64.5K | 1.32% | 24 |
|
|
2019
Q1 | $2.09M | Buy |
11,022
+465
| +4% | +$88.8K | 1.37% | 23 |
|
|
2018
Q4 | $2.06M | Sell |
10,557
-315
| -3% | -$61.5K | 1.51% | 21 |
|
|
2018
Q3 | $2.25M | Buy |
10,872
+65
| +0.6% | +$12.8K | 1.38% | 21 |
|
|
2018
Q2 | $2M | Buy |
10,807
+480
| +5% | +$84.9K | 1.3% | 21 |
|
|
2018
Q1 | $1.76M | Buy |
10,327
+395
| +4% | +$72.5K | 1.19% | 26 |
|
|
2017
Q4 | $1.73M | Buy |
+9,932
| New | +$1.76M | 1.13% | 27 |
|
Other funds holding AMGN
Sawyer & Company's AMGN Position: Q2 2026 in Review
Sawyer & Company reduced its Amgen (AMGN) stake by 0.69% in Q2 2026, selling an estimated $37.3K and leaving 15,704 shares worth $5.69M. The position accounts for 1.91% of the portfolio, ranked #12.
Sawyer & Company first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sawyer & Company held 15,704 shares of Amgen worth $5.69M as of Q2 2026.
- Sawyer & Company sold 109 Amgen shares in Q2 2026, an estimated $37.3K.
- Amgen made up 1.91% of Sawyer & Company's portfolio in Q2 2026, its #12 holding.
- Sawyer & Company first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.